Tag: HFX AdaptivAI
Nevro announces launch of “only AI-driven technology in spinal cord stimulation”
Nevro Corporation has announced the US Food and Drug Administration (FDA) approval and limited market release of HFX iQ with HFX AdaptivAI—a responsive, personalised...
